New Insight of Antiretroviral Drug Efavirenz as Anticancer Agents for Breast Cancer Therapy

Cancer Cell & Microenvironment
doi 10.14800/ccm.319
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Smart Science and Technology, LLC

Related search

New Role for an Established Drug? Bisphosphonates as Potential Anticancer Agents

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2011English

A New Platinum(II) Compound Anticancer Drug Candidate With Selective Cytotoxicity for Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

‘Covering the Tail’ After Stopping Efavirenz-Based Antiretroviral Therapy

Southern African Journal of HIV Medicine
Infectious Diseases
2020English

Endocrinology and Hormone Therapy in Breast Cancer: New Insight Into Estrogen Receptor-Α Function and Its Implication for Endocrine Therapy Resistance in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties

2011English

Progestin Therapy of Breast Cancer: Comparison of Agents.

BMJ
1967English

A New Direction for Breast Cancer Therapy

Science
MultidisciplinaryPhilosophy of ScienceHistory
2016English

Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy

Cancers
Cancer ResearchOncology
2019English

Breast Cancer Therapy Annual – Today's Drug Treatment of Cancer?

Breast Cancer Research
Cancer ResearchOncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy